Concepedia

Mark D. Lanigan

MD

8

Publications

532

Citations

8

H-Index

1998

Active since

Affiliations

University of California, Irvine(Current)

Commonwealth Scientific and Industrial Research Organisation

Australian Centre for Disease Preparedness

University of Florida

BioChem Technology (United States)

Mark D. Lanigan is an author at University of California, Irvine specializing in medicine, cellular physiology, and signal transduction.

Top concepts

Publications per year

1998–2008

8

Publications

8

ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide

Katalin Kálmán, Michael W. Pennington, Mark D. Lanigan et al. · Journal of Biological Chemistry · 1998 · 254 citations · Full text

, , +11

Structure-guided Transformation of Charybdotoxin Yields an Analog That Selectively Targets Ca2+-activated over Voltage-gated K+ Channels

Heiko Rauer, Mark D. Lanigan, Michael W. Pennington et al. · Journal of Biological Chemistry · 2000 · 108 citations · Full text

Mutating a Critical Lysine in ShK Toxin Alters Its Binding Configuration in the Pore−Vestibule Region of the Voltage-Gated Potassium Channel, Kv1.3

Mark D. Lanigan, Katalin Kálmán, Yann Lefievre et al. · Biochemistry · 2002 · 59 citations

Role of Disulfide Bonds in the Structure and Potassium Channel Blocking Activity of ShK Toxin

Michael W. Pennington, Mark D. Lanigan, Katalin Kálmán et al. · Biochemistry · 1999 · 37 citations

Mycobacterial proteome extraction: Comparison of disruption methods

Mark D. Lanigan, Jill Vaughan, Brian J. Shiell et al. · PROTEOMICS · 2004 · 34 citations

Rows per page

1–5 of 8